Rotavirus immune responses and correlates of protection.
about
Intestinal Innate Antiviral Immunity and Immunobiotics: Beneficial Effects against Rotavirus InfectionDelayed Dosing of Oral Rotavirus Vaccine Demonstrates Decreased Risk of Rotavirus Gastroenteritis Associated With Serum Zinc: A Randomized Controlled Trial.Virulence-associated genome mutations of murine rotavirus identified by alternating serial passages in mice and cell cultures.Immunobiotic Lactobacillus rhamnosus strains differentially modulate antiviral immune response in porcine intestinal epithelial and antigen presenting cells.Association of serum anti-rotavirus immunoglobulin A antibody seropositivity and protection against severe rotavirus gastroenteritis: analysis of clinical trials of human rotavirus vaccine.Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo.Putative E3 ubiquitin ligase of human rotavirus inhibits NF-κB activation by using molecular mimicry to target β-TrCP.Correlates of protection for rotavirus vaccines: Possible alternative trial endpoints, opportunities, and challenges.Protection against live rotavirus challenge in mice induced by parenteral and mucosal delivery of VP6 subunit rotavirus vaccineSkin Vaccination against Rotavirus Using Microneedles: Proof of Concept in Gnotobiotic PigletsA Randomized, Controlled Trial of the Impact of Alternative Dosing Schedules on the Immune Response to Human Rotavirus Vaccine in Rural Ghanaian Infants.Noninterference of Rotavirus Vaccine With Measles-Rubella Vaccine at 9 Months of Age and Improvements in Antirotavirus Immunity: A Randomized Trial.Maternal Helminth Infection Is Associated With Higher Infant Immunoglobulin A Titers to Antigen in Orally Administered Vaccines.Reinfection of adult cattle with rotavirus B during repeated outbreaks of epidemic diarrhea.Rotavirus NSP1 mediates degradation of interferon regulatory factors through targeting of the dimerization domainRotavirus NSP1 protein inhibits interferon-mediated STAT1 activation.Rotavirus specific plasma secretory immunoglobulin in children with acute gastroenteritis and children vaccinated with an attenuated human rotavirus vaccine.Circulating human rotavirus specific CD4 T cells identified with a class II tetramer express the intestinal homing receptors α4β7 and CCR9.Group A rotavirus universal mass vaccination: how and to what extent will selective pressure influence prevalence of rotavirus genotypes?Human rotavirus virus-like particle vaccines evaluated in a neonatal gnotobiotic pig model of human rotavirus disease.Correlates of protection against human rotavirus disease and the factors influencing protection in low-income settings.Mutations in toll-like receptor 3 are associated with elevated levels of rotavirus-specific IgG antibodies in IgA-deficient but not IgA-sufficient individuals.Complex correlates of protection after vaccination.Interference of Monovalent, Bivalent, and Trivalent Oral Poliovirus Vaccines on Monovalent Rotavirus Vaccine Immunogenicity in Rural Bangladesh.Postdose 3 G1 serum neutralizing antibody as correlate of protection for pentavalent rotavirus vaccine.Rotavirus Recombinant VP6 Nanotubes Act as an Immunomodulator and Delivery Vehicle for Norovirus Virus-Like ParticlesExpression of human rotavirus chimeric fusion proteins from replicating but non disseminating adenovectors and elicitation of rotavirus-specific immune responses in mice.Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease.Hematopoietic LTβR deficiency results in skewed T cell cytokine profiles during a mucosal viral infection.Antiviral effects of Lactobacillus ruminis SPM0211 and Bifidobacterium longum SPM1205 and SPM1206 on rotavirus-infected Caco-2 cells and a neonatal mouse model.Comparative In Vitro and In Vivo Studies of Porcine Rotavirus G9P[13] and Human Rotavirus Wa G1P[8].Rotavirus infection.Differences of Rotavirus Vaccine Effectiveness by Country: Likely Causes and Contributing Factors.Estimating the incidence of rotavirus infection in children from India and Malawi from serial anti-rotavirus IgA titresMHC class I expression in intestinal cells is reduced by rotavirus infection and increased in bystander cells lacking rotavirus antigen.Monitoring shedding of five genotypes of RotaTeq vaccine viruses by genotype-specific real-time RT-PCR assays.Live viral vaccines in immunocompromised patientsl-Isoleucine Administration Alleviates Rotavirus Infection and Immune Response in the Weaned Piglet Model
P2860
Q28074046-8BE71859-40D4-46D6-89C7-EE9177B5BFA4Q30276748-1A39A251-9607-4978-AB6F-F125F5FA0F0CQ33602861-253A6F37-C8AB-47A8-B80B-BE039D66FEECQ33673989-02FDE1AE-AB48-48C3-A44A-2F7DA7EC72CCQ34290838-6D342490-1C9E-4A6E-B7DE-FB991CEED2B6Q34291161-BDCD261C-276B-47E0-A57B-DFB8D107E71FQ35072342-620741A0-68F6-4FD9-9E6C-84F3615A7179Q35886464-72AFA3F6-565F-4815-A865-39CB387720BEQ35941247-F261E1C4-4980-4FD4-8C35-5388A329310CQ36185718-00A694AA-C8A1-446D-99CE-C2600E8246B1Q36871949-80E2AF2C-0F61-4A22-B326-8D0B55FF2824Q36871954-C495F7E4-89F4-4569-AA06-0A6514A6385CQ36931797-02A25BD3-786E-4316-8881-C54B80329863Q37046059-5B22F20F-E5F8-440C-BAB4-370CDEEAA1BFQ37123575-26131269-89FF-4DE6-A20C-2A5CD33678CDQ37547591-54860D57-AF91-434B-BA06-E67C12D1D2AEQ37694873-DA0E3295-C678-46B6-B133-C05D1595631AQ37707872-340204D0-2150-476C-8E85-81CD0B729811Q38068232-20ECE650-3B16-497C-B2EE-218CC8EB70C7Q38081968-B2BA775E-125F-4490-B1A2-BA3874CFA095Q38281298-C29C7C35-ACDD-4CB3-8FCB-6711969A7B0DQ38320849-A5ECD3EF-4B85-4A04-AD61-57BB761367BDQ38456515-C4941BCA-1A93-4356-9590-AC38FF64FBE5Q38501139-3781681C-5D8F-40D7-851C-9616B0DAB1AEQ38610724-D312DAC0-93F3-40F9-AF03-10C314DC313CQ38743049-D75980AE-3D88-4576-83C4-D19EDD9B76EEQ39190586-E693A5D2-3C48-4AE9-A64A-356A6DA641ADQ40254093-73B42450-44A0-4B05-AF7B-49A33E11E756Q40874904-451C13DA-1D5B-4E1B-A7A5-5ABE0F5AA86FQ40936727-AAADBDC1-CC2B-47D2-85D2-4A0269792496Q40952104-B865A5FD-C2DC-44DA-9738-3502F9D4940DQ46152582-54C8C9D9-C964-4D86-8BF2-70BB2DBC35ADQ46243057-A43CCFC1-33A1-4CB2-A39C-950807157C70Q47005046-C1B1C4C2-525D-417F-9F0A-B7A85610A652Q47222641-B9ACE4A5-6CB2-4FB9-A7D8-4E957F374336Q54094430-DA52A401-131D-4AED-8C39-477013DBC7DBQ56765765-C115AC8B-40CE-4A67-AC4B-21BDD243FA60Q57099973-956965E5-DF0B-451C-9385-E681CBEA2816
P2860
Rotavirus immune responses and correlates of protection.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Rotavirus immune responses and correlates of protection.
@ast
Rotavirus immune responses and correlates of protection.
@en
type
label
Rotavirus immune responses and correlates of protection.
@ast
Rotavirus immune responses and correlates of protection.
@en
prefLabel
Rotavirus immune responses and correlates of protection.
@ast
Rotavirus immune responses and correlates of protection.
@en
P2860
P1476
Rotavirus immune responses and correlates of protection.
@en
P2093
Manuel A Franco
P2860
P304
P356
10.1016/J.COVIRO.2012.05.003
P577
2012-06-05T00:00:00Z